Identification of Benzidine Metabolites in Rats by Gas Chromatography/Mass Selective Detector and its Toxicity in vitro

Gas-Chromatography/Mass Selective Detector를 사용하여 쥐의 뇨시료 중 benzidine 대사체의 확인 및 in vitro 독성

  • 류재천 (한국과학기술연구원 생체대사연구센터 독성연구실) ;
  • 권오승 (한국과학기술연구원 생체대사연구센터 독성연구실)
  • Published : 2000.10.01

Abstract

Metabolism study of the dye, benzidine, was performed by gas chromatography-mass selective detector (GC/MSD) in the urine of rats orally administered 100 mg/kg benzidine. Urine samples were collected in metabolic cages for 0-24, 24-48, and 48-72 hrs. Ten ml of the urine was extracted with XAD-2 resin and the XAD-2 column was eluted with methanol. After evaporation, benzidine and its metabolites were extracted with diethyl ether (for non-conjugated fraction). For conjugated metabolites, $\beta$-glucu-ronidase was added to the aqueous layer that was incubated for 1 hr at 5$0^{\circ}C$ and the aqueous layer was extracted as in non-conjugated fraction. Aliquot of trimethylsilylated derivatives was applied to the GC/MSD. The mutagenicity of benzidine and its acetylated metabolites was tested by histidine/reversion assay. Five metabolites observed and confirmed either by electron impact and chemical ionization modes of the GC/MSD, or authentic compounds were monoacetyl-, diacetyl-, hydroxyacetyl-, hydroxydiacetyl-, and hydroxy-benzidine. Monoacetyl-benzidine was more potent than benzidine in histidine/reversion assay. This data indicates that monoacetylation of benzidine may be one of the metabolites produced in metabolic activation process.

Keywords

References

  1. Mutat. Res. v.182 no.5 Comparative activation of 3,3'-dichlo- robenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P450. Iba. M. M
  2. Appl. Environ. Microbiol. v.50 no.1 Metabolism of the benzidine-based azo dye Direct Black 38 by human intestinal microbiota. Manning. B. W;Cerniglia. C. E;Federle. T. W
  3. Carcinogenesis v.6 no.4 Prostaglandin H synthase oxidation of benzidine and o-dianisidine: reduction and conjugation of activated amines by thiols. Wise. R. W;Zenser. T. V;Davis. B. B
  4. Mutat. Res. v.31 Methods for detecting carcinogens and mutagens with Salmonella/mammalian microsome mutagenicity test Ames. B;McCann. J;Yamasaki. E
  5. Carcinogenesis v.11 no.1 Metabolism and disposition of benzidine in dog. Lakshmi. V. M;Mattammal. M. B;Spry. L. A;Kadlubar. F. F;Zenser. T. V;Davis. B. B
  6. Drug Metab. Dispos. v.26 no.9 N-glucurinidation of benzidine and its metanolites. Role in bladder cancer Zenser. T. V;Lakshmi. V. M;Davis. B. B
  7. Carcinogenesis v.13 no.7 Role of N-glucuronidation in benzidine-induced bladder cancer in dog. Babu. S.R;Lakshmi. V.M;Hsu. F.F;Zenser. T.V;Davis. B. B
  8. Carconogenesis v.14 N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Hayes. R. B;Bi. W;Rithman. N;Broley. F;Caporaso. N;Feng. P;You. X;Yin. S;Woosley. R. L;Meyer. U. A
  9. Ann. Rev. Pharmacol. Toxicol. v.30 Prostaglandin H synthase and xenobiotic oxidation. Eling. T. E;Thompson. D. C;Foureman. G. L;Curtis. J. F;Hughes. M. F
  10. Biochem. Biophys. Act. v.948 Acetylator genotype and arylamine-induced carcinogens. Hein. D. W
  11. Drug Metab. Rev. v.26 Metabolic activation of N-hydroxylated metabolites of carcinogenic and mutagenic arylamines and arylamides by esterfication. Kato. R;Yamazoe. Y
  12. Toxicol. Appl. Pharmacol. v.72 Disposition of the aromatic amine, benzidine, in the rat: Characterization of mutagenic urinary and biliary metabolites Lynn. R. K;Gravie-Gould. C. T;Milam. D. F;Scott. K. F;Eastman. C. L;Ilias. A. M;Rodgers. R. M